VIVA

This channel contains news about the annual Vascular Interventional Advances (VIVA) conference. VIVA is a premier conference for new techniques and technologies to treat vascular disease. This includes the areas of peripheral artery disease (PAD), critical limb ischemia (CLI), endovascular repair and venous therapies.

A lone vendor booth in a sea of open space in a corner of the expo floor at HIMSS 2021 this week. A large number of vendors decided to pull out of exhibiting at HIMSS in recent weeks because the host city of Las Vegas saw a major surge of COVID cases over July, reaching a 20.2% positivity rate on the day HIMSS began.

Blog | Coronavirus (COVID-19)

HIMSS 2021 Showed What to Expect From In-person Healthcare Conferences During the COVID Pandemic

The in-person 2021 Healthcare Information Management Systems Society (HIMSS) meeting planned for Aug. 9-13 appeared to ...

August 13, 2021

News | VIVA

The Latest Vascular Interventional Clinical Data Presented at VIVA 2020

October 5, 2020 — The Vascular Interventional Advances (VIVA) virtual conference will feature 10 late-breaking clinical ...

October 05, 2020

The ClotTriever system (Inari Medical), a mechanical thrombectomy system FDA 510(k) cleared for the nonsurgical removal of soft thrombi and emboli from peripheral blood vessels. #VIVA19 #VIVA2019

News | Deep Vein Thrombosis (DVT)

DVT ClotTriever (CLOUT) Registry Shows Significant Improvement

November 7, 2019 — The ClotTriever Outcomes (CLOUT) Registry is evaluating real-world patient outcomes following ...

November 14, 2019

News | Peripheral Artery Disease (PAD)

The ULYSSE Registry Shows Benefit of Ultrasoundplasty Before Below-the-knee Interventions

November 7, 2019 — Ultrasoundplasty before angioplasty for below-the-knee lesions (BTK) lesions may improve clinical ...

November 14, 2019

News | Peripheral Artery Disease (PAD)

Adventitial Temsirolimus Injections in BTK Lesions Improved Outcomes in TANGO Trial

November 14, 2019 — There were positive results in the TANGO Trial is a phase 2, dose escalation, double-blinded trial ...

November 14, 2019

The LimFlow procedure permanently bypasses unreconstructable arteries and leverages healthier veins as a conduit to create new routes to perfuse tissue in the foot. #VIVA #VIVA19 #VIVA2019

News | Peripheral Artery Disease (PAD)

LimFlow Procedure Successful in Bypassing Unreconstructable Arteries in Limb-threatening Ischemia

November 14, 2019 — Results were positive for the multicenter PROMISE I Trial represents the first human use in the ...

November 14, 2019

The IN.PACT Arteriovenous (AV) Access randomized trial evaluating the safety and effectiveness of the Medtronic IN.PACT AV Access drug-coated balloon (DCB) met both of its endpoints, in data presented at the 2019 Vascular Interventional Advances (VIVA) annual meeting. #VIVA #VIVA19 #VIVA2019

News | Drug-Eluting Balloons

IN.PACT AV Access 6-Month Data Show Increased Vessel Patency

November 7, 2019 — The IN.PACT Arteriovenous (AV) Access randomized trial evaluating the safety and effectiveness of the ...

November 14, 2019

The Rex Medical Revolution rotational atherectomy system incorporates continuous aspiration and has a dual indication for atherectomy and thrombectomy. #VICA19 #VIVA2019

News | Atherectomy Devices

Revolution Rotational Atherectomy System Effective in IDE Experience

November 7, 2019 — The REVEAL FDA investigational device exemption (IDE) trial confirmed a favorable safety and ...

November 11, 2019

The Endospan Ltd. Nexus aortic arch stent graft is a CE mark–approved, off-the-shelf system for endovascular treatment of pathologies extending or involving the aortic arch. #VIVA19 #VIVA2019

News | Endovascular Aortic Repair

Nexus Arch Branch Stent Graft System Shows Positive Mid-term Results

November 7, 2019 — The Endospan Ltd. Nexus aortic arch stent graft is a CE mark–approved, off-the-shelf system for ...

November 11, 2019

The repuncturable Supera vascular mimetic peripheral stent system from Abbott Vascular was shown to manage bulky, heavily calcified CFA disease due to its extreme crush resistance in the VMI-CFA study. #VIVA #VIVA19 #VIVA2019

News | Stents Carotid

Supera Safe to use for Femoral Stenting Versus Surgery in VMI-CFA Trial

November 11, 2019 — Although common femoral artery (CFA) endarterectomy is still considered the gold standard treatment ...

November 11, 2019

Indigo System CAT RX Aspiration Catheter and Penumbra Engine

News

Indigo Aspiration System IDE Trial for Acute Pulmonary Embolism Meets Primary Safety and Efficacy

November 8, 2019 — Penumbra Inc. announced that the EXTRACT-PE trial successfully met the primary endpoints ...

November 08, 2019

News

One-Year Results of the DISAPEAR Registry Positive for Absorb Stent

November 8, 2019 — The Absorb bioresorbable stent (BVS) demonstrated good patency and clinical outcomes in patients with ...

November 08, 2019

News | Stents Bioresorbable

Bioresorbable Stent Shows Good 5-Year Outcomes in ABSORB BTK Trial

November 7, 2019 — Although the Abbott Absorb fully bioresorbable drug-eluting stent (DES) was taken off the market due ...

November 07, 2019

In.Pact Admiral drug-coated balloon (DCB). #VIVA #VIVA19 #VIVA2019

News | Drug-Eluting Balloons

Drug-coated Balloon Maintains Good Outcomes in 4-Year IN.PACT Global Study Data

November 7, 2019 — Real-world, four-year study results of the In.Pact Admiral drug-coated balloon (DCB) demonstrate long ...

November 07, 2019

The AngioDynamics/Eximo Medical B-Laser represents a new atherectomy device. #VIVA2019 #VIVA #VIVA19

News | Atherectomy Devices

No Difference Between Drug-coated Balloons and Plain Balloons After Laser Atherectomy

November 7, 2019 — There was no difference between drug-coated balloons (DCB) vs. plain old balloon angioplasty (POBA) ...

November 07, 2019